News

You are here

CE-IVD marked
Novosanis achieved two major milestones - our Colli-Pee ® Small Volumes product line is now CE-Marked.
In view of the spread of Covid-19 (coronavirus) in our country and across the world, our topmost priority is the health and safety of all our customers and employees. Our team will be...
Novosanis celebrates 7 years
Today Novosanis Turns 7! On our 7th anniversary, we are proud to share some key highlights.
Eurogin 2019
It's been a few weeks since we've been back from Eurogin 2019. Read our news item sharing a few highlights of our trip and the conference.
First-void urine to detect Chlamydia prevalence in the Belgian population
Researchers at The Sciensano Institute in Belgium will be using urine collected through Colli-Pee ® to understand Chlamydia presence in all ages and genders in the Belgium population.
Novosanis co-awarded prestigious Eurostar grant
Novosanis has been co-awarded a CASUS grant, which allows to build a next-generation Colli-Pee ® that will be used in a molecular screening solution for cervical cancer.
HPV linked to infertility - Infertility Awareness Week
HPV not only has links to cancer, but also infertility
INJECT-ID
Novosanis receives grant from Interreg CrossCare to build a next-generation of its unique and patented intradermal drug delivery device, VAX-ID, in collaboration with living labs Happy...
Royal Mission Mexico
A wrap to an exciting and eventful week! Our Product designer, Alejandra Ríos Cortés, represented Novosanis at the Royal Mission, an initiative led by Princess Astrid of Belgium, to boost...
HPV Vaccination Impact Study Rwanda
Today, 4 February, is #worldcancerday. Cervical cancer is one of the most preventable forms of cancer if it’s detected early. HPV urine testing can offer a solution for screening next to...
Movember
The month of November marked Movember. Our latest Newsletter covering all about Men's Health is live. Check it out!
VAX-ID intradermal drug delivery device
Timothi Van Mulder will present Novosanis' breakthrough results on the development of a painless injection device for children at 12 th Vaccine Congress in Budapest, Hungary from September...

Pages